These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 7326565)
1. Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. Williams FJ; Walshe JM Brain; 1981 Dec; 104(Pt 4):735-52. PubMed ID: 7326565 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Walshe JM Lancet; 1982 Mar; 1(8273):643-7. PubMed ID: 6121964 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine). Dubois RS; Rodgerson DO; Hambidge KM J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883 [TBL] [Abstract][Full Text] [Related]
4. Neurological abnormalities in Wilson's disease are reversible. Lingam S; Wilson J; Nazer H; Mowat AP Neuropediatrics; 1987 Feb; 18(1):11-2. PubMed ID: 3561699 [TBL] [Abstract][Full Text] [Related]
5. Serial changes of cranial computerized tomographic findings in Wilson disease during D-penicillamine therapy. Mizutani N; Maehara M; Negoro T; Watanabe K Brain Dev; 1983; 5(1):48-52. PubMed ID: 6846733 [TBL] [Abstract][Full Text] [Related]
6. Computerized cranial tomography in presymptomatic and hepatic form of Wilson's disease. Dettori P; Rachele MG; Demelia L; Pelaghi AE; Nurchi AM; Aromando P; Giagheddu M Eur Neurol; 1984; 23(1):56-63. PubMed ID: 6714278 [TBL] [Abstract][Full Text] [Related]
7. [A case of Wilson's disease recovering from severe brain damage--special reference to trientine and D-penicillamine therapy]. Ishitsu T; Chikazawa S No To Hattatsu; 1989 May; 21(3):294-6. PubMed ID: 2736129 [No Abstract] [Full Text] [Related]
8. Computed tomography in hepatolenticular degeneration (Wilson's disease). Chen XR; Shen TZ; Li NZ; Liu DK Comput Radiol; 1983; 7(6):361-4. PubMed ID: 6641205 [TBL] [Abstract][Full Text] [Related]
9. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations. Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347 [TBL] [Abstract][Full Text] [Related]
10. Practical recommendations and new therapies for Wilson's disease. Brewer GJ Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report. Haslam RH; Sass-Kortsak A; Stout W; Berg M Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976 [TBL] [Abstract][Full Text] [Related]
12. Wilson's disease in one identical twin and treatment by triethylene tetramine 2HCl in another case. Watson RG Ulster Med J; 1983; 52(1):48-53. PubMed ID: 6687321 [No Abstract] [Full Text] [Related]
13. The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease. Asatoor AM; Milne MD; Walshe JM J R Coll Physicians Lond; 1983 Apr; 17(2):122-5. PubMed ID: 6842414 [TBL] [Abstract][Full Text] [Related]
14. [Computer tomographic studies in Wilson disease]. Nix WA; Ludwig G; Backmund H Nervenarzt; 1984 Oct; 55(10):544-8. PubMed ID: 6504223 [TBL] [Abstract][Full Text] [Related]
15. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. Scheinberg IH; Jaffe ME; Sternlieb I N Engl J Med; 1987 Jul; 317(4):209-13. PubMed ID: 3600712 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation? Schilsky ML Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695 [TBL] [Abstract][Full Text] [Related]
17. Wilson's disease, an end to the search for new therapy? May PM; Jones DC; Williams DR Lancet; 1982 May; 1(8281):1127. PubMed ID: 6122924 [No Abstract] [Full Text] [Related]
19. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease. Walshe JM QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540 [TBL] [Abstract][Full Text] [Related]